What’s New

Super-thick amniotic membrane graft offers an alternative for ocular surface reconstruction

This study evaluated super-thick amniotic membrane grafts (ST-AMGs) for ocular surface reconstruction. Source: AAO

Posted on: Feb 4 2019
By: Saratoga Opthalmology
Leave a response

Week in review: Virtual breakthrough, broken records, cost-cutting app

This week, virtual reality goggles could speed glaucoma diagnosis, the FDA celebrates a record year of device approvals and a startup is screening kids’ eyes with an app instead of a $20,000 device. Source: AAO

Posted on: Feb 1 2019
By: Saratoga Opthalmology
Leave a response

Intereye RNFL differences useful for predicting optic nerve lesion in multiple sclerosis

The optic nerve is a frequent site for involvement in multiple sclerosis (MS). Using OCT, the authors sought to determine optimal thresholds for intereye difference in peripapillary retinal nerve fiber layer (RNFL) thickness that are most predictive of a unilateral optic nerve lesion. Source: AAO

Posted on: Feb 1 2019
By: Saratoga Opthalmology
Leave a response

Androgen skin patch improves signs, symptoms of dry eye disease

Investigators from Thailand prospectively evaluated the efficacy of transdermal androgen therapy for treating dry eye in patients with androgen deficiency. Source: AAO

Posted on: Jan 31 2019
By: Saratoga Opthalmology
Leave a response

Conventional phacoemulsification, FLACS yield comparable clinical outcomes

This study compared the clinical outcomes of conventional phacoemulsification versus femtosecond laser-assisted cataract surgery at a single center. Source: AAO

Posted on: Jan 30 2019
By: Saratoga Opthalmology
Leave a response

Atropine drops effectively control myopia progression

This study evaluated the efficacy and safety of low-concentration (0.05%, 0.025% and 0.01%) atropine eye drops compared with placebo over a 1-year period. Source: AAO

Posted on: Jan 29 2019
By: Saratoga Opthalmology
Leave a response

Alert: Allergan voluntarily recalls 22 lots of Ozurdex

Due to the possibility of silicone contamination, Allergan has issued an “urgent drug recall” of their dexamethasone implant, Ozurdex. Source: AAO

Posted on: Jan 28 2019
By: Saratoga Opthalmology
Leave a response

Promising checkpoint inhibitor therapy for metastatic conjunctival melanoma

Researchers investigated whether programmed cell death 1 (PD-1) inhibitors can treat metastatic conjunctival melanoma. Source: AAO

Posted on: Jan 28 2019
By: Saratoga Opthalmology
Leave a response

Week in review: Squid centerfold, star studies, freeze-dried salve

This week, a Caribbean Reef Squid’s exotic pupil graces the pages of Ophthalmology, a blind astrophysicist uses sonification to study the stars and freeze-dried stem cells may be just the thing to cure corneal injuries. Source: AAO